Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis iap'

Search results for: 'research area apoptosis iap'

Items 21-30 of 65

Page
per page
  1. Q-VD(OMe)-OPh
    A8165 Q-VD(OMe)-OPh
     6 Citation
    Target: Caspases
    Summary: Pan-caspase inhibitor
      ≥26.35 mg/mL
  2. TW-37
    A4234 TW-37
     1 Citation
    Target: Bcl-2|Bcl-xl|Mcl-1
    Summary: Bcl-2 inhibitor, inhibits Bcl-2,Bcl-XL and Mcl-1
      insoluble in H2O; ≥19.75 mg/mL
  3. WEHI-539 hydrochloride
    A8634 WEHI-539 hydrochloride
     1 Citation
    Summary: Bcl-xL inhibitor,high affinity and selective
      ≥28.55 mg/mL
  4. D609
    A3343 D609
    Target: PC-PLC
    Summary: PC-PLC inhibitor
      ≥12.7 mg/mL
  5. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  6. Lenalidomide (CC-5013)
    A4211 Lenalidomide (CC-5013)
    Target: angiogenesis
    Summary: Antineoplastic agent,inhibits angiogenesis
      insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
  7. Pomalidomide (CC-4047)
    A4212 Pomalidomide (CC-4047)
    Summary: Immunomodulator,antumor/anti-angiogenic
      insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
  8. MIM1
    A4465 MIM1
     1 Citation
    Target: Mcl-1
    Summary: Mcl-1 Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥12.15 mg/mL
  9. CID 755673
    A8678 CID 755673
    Target: PKD
    Summary: PKD inhibitor
  10. ABT-199
    A8194 ABT-199
     14 Citation
    Target: Bcl-2
    Summary: Bcl-2 inhibitor,potent and selective
      ≥43.42 mg/mL

Items 21-30 of 65

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 60item
  2. Natural Products 4item
  3. Protein 2item
  4. Peptides & Proteins 3item
  5. Lab Reagents 1 item
Specificity
  1. Selective 29item
Reversibility
  1. Irreversible 4item
Target
  1. Caspases 5item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Histone Deacetylases (HDACs) 3item
  5. Inhibitor of apoptosis proteins (IAP) 1 item
  6. Bcl-2 5item
  7. Raf 2item
  8. Aurora Kinases 1 item
  9. Bcl-xl 2item
  10. MDM2 1 item
  11. AP-1 1 item
  12. DT-diaphorases 1 item
  13. GSK-3 1 item
  14. VEGFR 2item
  15. PDGFR 2item
  16. c-Kit 2item
  17. RET 1 item
  18. Mcl-1 2item
  19. Thymidylate Synthase 1 item
  20. Nrf2 1 item
  21. Sir2-like Family Deacetylases (Sirtuins) 1 item
  22. Aminopeptidases 1 item
  23. STAT 1 item
  24. Estrogen and Related Receptors 1 item
  25. EGFR 1 item
  26. Hypoxia Inducible Factors (HIFs) 1 item
  27. JAK 3item
  28. HSP90 1 item
  29. Topoisomerases 1 item
  30. Cytochrome P450 (CYP450) 1 item
  31. MK2 1 item
  32. Autophagy 1 item
  33. NADPH Oxidases 1 item
  34. MAGL 1 item
  35. Histamine H1 Receptors 1 item
  36. TRP Channel 1 item
  37. Glucocorticoid Receptors 1 item
  38. Cdc7 1 item
  39. angiogenesis 1 item
  40. c-RET 1 item
  41. FPTase 1 item
  42. sodium channels 1 item
  43. p53 4item
  44. cysteine protease 1 item
  45. HDM2 ubiquitin ligase 1 item
  46. PC-PLC 1 item
  47. Glucosidases 1 item
  48. HIV 1 item
  49. Histone Acetyltransferases (HATs) 1 item
  50. Telomerases 1 item
  51. Tyrosinases 1 item
  52. HSP70 1 item
  53. phosphatidylinositol kinase 1 item
  54. Adenosine Deaminases 1 item
  55. p21 1 item
  56. DHFR 1 item
  57. GARFT 1 item
  58. RHA 1 item
  59. TRPC channel 1 item
  60. PKD 1 item
  61. Bcl-w 1 item
  62. Bax 1 item
  63. NS3/4a Proteases 1 item
Related Disease
  1. Breast Cancer 7item
  2. Cancer 29item
  3. Chronic Lymphocytic Leukemia 1 item
  4. Chronic Myeloproliferative Disorders 1 item
  5. Colon Cancer 2item
  6. Colon Carcinoma 1 item
  7. Colorectal Cancer 1 item
  8. Glioblastoma 2item
  9. HCV 1 item
  10. Inflammatory Diseases 1 item
  11. Leukemia 1 item
  12. Lymphoma 3item
  13. Melanoma 2item
  14. Multiple Myeloma 1 item
  15. Myelofibrosis 1 item
  16. Non-small Cell Lung Cancer 1 item
  17. Pain Relief 1 item
  18. Pancreatic Cancer 2item
  19. Pentacyclic Triterpenoid 1 item
  20. Prostate Cancer 5item
  21. Pulmonary Fibrosis 1 item
  22. Rheumatoid Arthritis 1 item
  23. Soft Tissue Sarcoma 1 item
  24. Type 2 Diabetes 1 item